AngioSoma Inc
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is base… Read more
AngioSoma Inc (GSTC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.013x
Based on the latest financial reports, AngioSoma Inc (GSTC) has a cash flow conversion efficiency ratio of 0.013x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-20.40K) by net assets ($-1.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
AngioSoma Inc - Cash Flow Conversion Efficiency Trend (2010–2023)
This chart illustrates how AngioSoma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
AngioSoma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AngioSoma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XRPR
BATS:XRPR
|
N/A |
|
Together Startup Network Ltd
TA:TGTR
|
-0.149x |
|
Konan Technology Inc.
KQ:402030
|
N/A |
|
Nuveen Multi-Asset Income Fund
NYSE:NMAI
|
-0.038x |
|
Cbd Life Sciences Inc
PINK:CBDL
|
0.106x |
|
J M AB
BE:JMM
|
0.070x |
|
ATEA (MKL.SG)
STU:MKL
|
0.027x |
|
Global Hemp Group Inc
PINK:GBHPF
|
0.000x |
Annual Cash Flow Conversion Efficiency for AngioSoma Inc (2010–2023)
The table below shows the annual cash flow conversion efficiency of AngioSoma Inc from 2010 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-09-30 | $-1.43 Million | $-205.76K | 0.144x | -47.58% |
| 2022-09-30 | $-1.19 Million | $-327.00K | 0.274x | -73.55% |
| 2021-09-30 | $-725.82K | $-751.23K | 1.035x | +184.61% |
| 2020-09-30 | $-659.22K | $-239.74K | 0.364x | -4.18% |
| 2019-09-30 | $-685.43K | $-260.14K | 0.380x | +83.50% |
| 2018-09-30 | $-870.73K | $-180.09K | 0.207x | +140.12% |
| 2017-09-30 | $-623.98K | $-53.74K | 0.086x | +142.09% |
| 2016-09-30 | $-843.09K | $-30.00K | 0.036x | +100.11% |
| 2015-09-30 | $12.64K | $-402.46K | -31.837x | -1169.09% |
| 2014-09-30 | $-104.44K | $-311.01K | 2.978x | +270.06% |
| 2013-09-30 | $245.28K | $-429.52K | -1.751x | -165.21% |
| 2012-09-30 | $-106.13K | $-285.02K | 2.686x | -50.45% |
| 2011-09-30 | $-9.68K | $-52.48K | 5.420x | +48197.32% |
| 2010-09-30 | $6.92K | $-78.00 | -0.011x | -- |